Cholesterol treatment is changing: Lipfendra, Inclisiran and new guidelines

NEW YORK: Cholesterol management is entering a new phase as new lipid-lowering therapies and updated clinical guidelines are expanding the options for people who need to reduce low-density lipoprotein cholesterol (LDL-C), commonly known as "bad" cholesterol.